文献速递主动脉疾病

一体式分叉支架移植物腔内修复孤立性腹主动脉夹层的中期结果

Contemporary Results of Endovascular Repair of Isolated Abdominal Aortic Dissection with Unibody Bifurcated Stent Grafts.
PubMed 文献 · Ann Vasc Surg · 2018-02-05

该回顾性研究评估了Aegis™-B一体式分叉支架移植物腔内治疗孤立性腹主动脉夹层(IAAD)的中期安全性和有效性。2008至2015年间共32例患者(21例男性,平均年龄58±18岁)接受治疗,技术成功率100%,平均随访30.71±16.36个月,无死亡、破裂、支架断裂或移位,所有患者1年时假腔完全血栓化且无假腔增长。

要点

  • Aegis™-B一体式分叉支架腔内修复IAAD技术成功率100%,中期随访安全有效。
  • 近端锚定区狭窄和远端主动脉狭窄分别见于34.4%和31.3%的患者。
  • 随访期间无死亡、破裂、支架断裂或移位,1年时全部假腔完全血栓化。

核心结论

  • 使用Aegis™-B系统腔内治疗IAAD似乎是安全有效的。
  • 该方案可为近端锚定区和远端主动脉狭窄的IAAD患者提供稳定牢固的固定。

研究设计与样本

  • 回顾性评估2008至2015年间32例IAAD患者(21例男性,平均年龄58±18岁),均接受Aegis™-B一体式分叉支架移植物腔内修复。

主要发现

  • 所有患者均经腔内手段治疗,初次技术成功率100%。
  • 平均随访30.71±16.36个月(范围8-56个月),未观察到死亡、破裂、支架断裂、材料失败或器械移位。
  • 所有患者1年时假腔完全血栓化,随访期间所有患者无假腔增长。

关键数值与推荐

  • 近端锚定区狭窄见于11例(34.4%)患者,远端主动脉狭窄见于10例(31.3%)患者。

临床怎么用

  • 对于近端锚定区和远端主动脉狭窄的IAAD患者,可考虑使用Aegis™-B一体式分叉支架移植物进行腔内修复。

局限性

  • 回顾性研究,样本量较小(32例),随访时间有限(平均30.71个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report the midterm safety and efficacy of the Aegis™-B (Microport, Shanghai, China) unibody bifurcated stent graft for endovascular treatment of isolated abdominal aortic dissection (IAAD). BACKGROUND: Isolated abdominal aorta dissection (IAAD) is a rare event. Endovascular stent grafts seem to offer an efficient therapeutic approach to treat IAAD. However, the relatively small diameter of the infrarenal aorta and aortic bifurcation remains the main anatomical limitation to endovascular repair. METHODS: Between 2008 and 2015, we retrospectively evaluated 32 IAAD patients (21 men; mean age 58 ± 18 years), who underwent endovascular repair using Aegis™-B unibody bifurcated stent graft. Narrow proximal landing zone and narrow distal aorta was present in 11 (34.4%) patients and 10 (31.3%) patients, respectively. In the follow-up period, aortic remodeling was observed with computed tomography angiography. RESULTS: All patients were treated by endovascular means, with a primary technical success rate of 100%. During a mean follow-up period of 30.71 ± 16.36 months (range, 8-56 months), no death, rupture, stent fracture, material failure, or device migration was observed. Complete false lumen thrombosis was observed in all patients at 1 year, and all patients were free from false lumen growth in the follow-up. CONCLUSIONS: Endovascular treatment of IAAD using the Aegis™-B system appears to be safe and effective. Results from this study suggest this algorithm can provide stable, secure fixation for IAAD patients with narrow proximal landing zone, and distal aorta.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Zhou M, Cai H, Li Z, et al. Contemporary Results of Endovascular Repair of Isolated Abdominal Aortic Dissection with Unibody Bifurcated Stent Grafts. Ann Vasc Surg. 2018. PMID: 29421419. doi:10.1016/j.avsg.2017.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。